Secretion and Contribution to Lipolysis of Gastric and Pancreatic Lipases During a Test Meal in Humans
Overview
Authors
Affiliations
Background: The aim of this study was to quantitatively evaluate the relative contributions to in vivo lipolysis of gastric and pancreatic lipases.
Methods: Gastric and pancreatic lipase secretions were measured, and their respective levels were determined in duodenal fluid during the digestion of a liquid test meal in healthy volunteers. Gastric lipase activity was clearly distinguished from that of pancreatic lipase by using both a specific enzymatic assay and an enzyme-linked immunosorbent assay. Lipolysis products were monitored throughout the digestion period.
Results: On a weight basis, the ratio of pancreatic lipase to gastric lipase total secretory outputs was found to be around four after 3 hours of digestion. The level of gastric hydrolysis was calculated to be 10% +/- 1% of the acyl chains released from the meal triglycerides. Gastric lipase remained active in the duodenum where it might still hydrolyze 7.5% of the triglyceride acyl chains.
Conclusions: Globally during the whole digestion period, gastric lipase might hydrolyze 17.5% of the triglyceride acyl chains. In other words, gastric lipase might hydrolyze 1 acyl chain of 4, which need to be hydrolyzed for a complete intestinal absorption of monoglycerides and free fatty acids resulting from the degradation of two triglyceride molecules.
Kokotou M Biomolecules. 2025; 14(12.
PMID: 39766309 PMC: 11674463. DOI: 10.3390/biom14121602.
Lucke A, Liesegang A, Kummerlen D, Czarniecki M, Wichert B Heliyon. 2024; 10(12):e33300.
PMID: 39022019 PMC: 11252939. DOI: 10.1016/j.heliyon.2024.e33300.
Current advances for protein digestibility.
Santos-Sanchez G, Miralles B, Brodkorb A, Dupont D, Egger L, Recio I Front Nutr. 2024; 11:1404538.
PMID: 38873563 PMC: 11174598. DOI: 10.3389/fnut.2024.1404538.
Couedelo L, Lennon S, Abrous H, Chamekh I, Bouju C, Griffon H Nutrients. 2024; 16(7).
PMID: 38613047 PMC: 11013230. DOI: 10.3390/nu16071014.
Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives.
Zhang W, Zhang Q, Cao Z, Zheng L, Hu W Pharmaceutics. 2023; 15(12).
PMID: 38140105 PMC: 10747965. DOI: 10.3390/pharmaceutics15122765.